X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 18/Jun 15:36

Healing by proxy: newly discovered drug may treat cancer and inflammation through indirect action

Scientists at the School of Biosciences and Veterinary Medicine at the University of Camerino (Italy) and CureLab Oncology (Boston) have uncovered the indirect therapeutic potential of Elenagen, a circular DNA encoding the p62/SQSTM1 protein. This discovery offers a new understanding of Elenagen’s recently reported anti-cancer effects and opens exciting possibilities for developing novel therapies for age- and inflammation-related diseases. The two [...]

Articles similaires

Sorry! Image not available at this time

Aethlon Medical receives HREC's approval for Hemopurifier cancer trial

pharmabiz.com - 20/Jun 00:00

Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...

New Strategy to Enhance Checkpoint Inhibitor Therapy for Cancer

medindia.net - 27/Jun 16:00

Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its ability to detect and...

Sorry! Image not available at this time

Why Are Comprehensive Solutions Important For Biologics?

texasnewstoday.com - 24/Jun 03:28

Biologics are a cornerstone of modern medicine, offering groundbreaking treatments for a wide range of diseases, including cancer, autoimmune...

Research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer

oncologynews.com.au - 18/Jun 16:59

Society of Nuclear Medicine and Molecular Imaging Annual Meeting Cleveland Clinic researchers have discovered a new location for a protein that helps...

Sorry! Image not available at this time

Raya Therapeutic announces supportive clinical results of fasudil in amyotrophic lateral sclerosis patients

pharmabiz.com - 18/Jun 00:00

Raya Therapeutic Inc., (Raya) a mission─driven company focused on the treatment of ALS and other neurodegenerative diseases, announced supportive...

Sorry! Image not available at this time

Vitamin B12 may help reduce inflammation, study finds

knowridge.com - 20/Jun 00:41

A recent study has illuminated a significant relationship between vitamin B12 levels and chronic inflammation, a culprit behind several severe health...

Sorry! Image not available at this time

Charles River Laboratories - Scotland: Clinical Veterinary Surgeon

pharmiweb.com - 25/Jun 00:00

Competitive: Charles River Laboratories - Scotland: For 75 years, Charles River employees have worked together to assist in the discovery,...

Sorry! Image not available at this time

Oncology Drugs Market Is Projected to Reach USD 474.06 Billion 2032, Growing at A Rate Of 8.83% To Forecast 2024-2032, According To Introspective Market Research.

mountaintoday.in - 19/Jun 14:28

Oncology Drugs Market Oncology is the branch of medicine that includes cancer prevention, diagnosis, treatment, and study. Cancer describes the...

Sorry! Image not available at this time

FDA Approves Tepylute (thiotepa) Ready-to-Dilute Injectable Formulation to Treat Breast Cancer and Ovarian Cancer

drugs.com - 28/Jun 22:06

CAMBRIDGE, Mass.--(BUSINESS WIRE) June 28, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced...

Sorry! Image not available at this time

CDR─Life expands pipeline of highly cancer─specific targeted therapies

pharmabiz.com - 27/Jun 00:00

CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion...

Les derniers communiqués

  • Aucun élément